Your browser doesn't support javascript.
loading
Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis.
Mohammed, Sabira; Thadathil, Nidheesh; Ohene-Marfo, Phoebe; Tran, Albert L; Van Der Veldt, Michael; Georgescu, Constantin; Oh, Sangphil; Nicklas, Evan H; Wang, Dawei; Haritha, Nair Hariprasad; Luo, Wenyi; Janknecht, Ralf; Miller, Benjamin F; Wren, Jonathan D; Freeman, Willard M; Deepa, Sathyaseelan S.
Afiliación
  • Mohammed S; Stephenson Cancer Center, Oklahoma City, Oklahoma.
  • Thadathil N; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Ohene-Marfo P; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Tran AL; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Van Der Veldt M; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Georgescu C; Genes and Human Disease Research Program, Oklahoma City, Oklahoma.
  • Oh S; Genes and Human Disease Research Program, Oklahoma City, Oklahoma.
  • Nicklas EH; Stephenson Cancer Center, Oklahoma City, Oklahoma.
  • Wang D; Department of Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Haritha NH; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Luo W; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Janknecht R; Stephenson Cancer Center, Oklahoma City, Oklahoma.
  • Miller BF; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Wren JD; Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Freeman WM; Stephenson Cancer Center, Oklahoma City, Oklahoma.
  • Deepa SS; Department of Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Mol Cancer Res ; 21(9): 933-946, 2023 09 01.
Article en En | MEDLINE | ID: mdl-37204757
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Enfermedad del Hígado Graso no Alcohólico / Neoplasias Hepáticas Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Enfermedad del Hígado Graso no Alcohólico / Neoplasias Hepáticas Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article